Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Topic choice contributes to the lower rate of NIH awards to African-American/black scientists.

Hoppe TA, Litovitz A, Willis KA, Meseroll RA, Perkins MJ, Hutchins BI, Davis AF, Lauer MS, Valantine HA, Anderson JM, Santangelo GM.

Sci Adv. 2019 Oct 9;5(10):eaaw7238. doi: 10.1126/sciadv.aaw7238. eCollection 2019 Oct.

2.

Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation.

Okada K, Honda Y, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Khush KK, Fearon WF.

Int J Cardiol. 2019 Sep 1;290:27-32. doi: 10.1016/j.ijcard.2019.04.018. Epub 2019 Apr 8.

PMID:
30987835
3.

Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.

Agbor-Enoh S, Wang Y, Tunc I, Jang MK, Davis A, De Vlaminck I, Luikart H, Shah PD, Timofte I, Brown AW, Marishta A, Bhatti K, Gorham S, Fideli U, Wylie J, Grimm D, Goodwin N, Yang Y, Patel K, Zhu J, Iacono A, Orens JB, Nathan SD, Marboe C, Berry GJ, Quake SR, Khush K, Valantine HA.

EBioMedicine. 2019 Feb;40:541-553. doi: 10.1016/j.ebiom.2018.12.029. Epub 2019 Jan 26.

4.

Long-term prognostic value of invasive and non-invasive measures early after heart transplantation.

Kobayashi Y, Kobayashi Y, Yang HM, Bouajila S, Luikart H, Nishi T, Choi DH, Schnittger I, Valantine HA, Khush KK, Yeung ACY, Haddad F, Fearon WF.

Int J Cardiol. 2018 Jun 1;260:31-35. doi: 10.1016/j.ijcard.2018.01.070.

PMID:
29622448
5.

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.

Agbor-Enoh S, Jackson AM, Tunc I, Berry GJ, Cochrane A, Grimm D, Davis A, Shah P, Brown AW, Wang Y, Timofte I, Shah P, Gorham S, Wylie J, Goodwin N, Jang MK, Marishta A, Bhatti K, Fideli U, Yang Y, Luikart H, Cao Z, Pirooznia M, Zhu J, Marboe C, Iacono A, Nathan SD, Orens J, Valantine HA, Khush K.

J Heart Lung Transplant. 2018 Jul;37(7):925-932. doi: 10.1016/j.healun.2018.01.1305. Epub 2018 Jan 31.

PMID:
29500138
7.

Impact of Asymmetric Dimethylarginine on Coronary Physiology Early After Heart Transplantation.

Parikh RV, Khush KK, Luikart H, Pargaonkar VS, Kobayashi Y, Lee JH, Sinha S, Cohen G, Valantine HA, Yeung AC, Fearon WF.

Am J Cardiol. 2017 Sep 15;120(6):1020-1025. doi: 10.1016/j.amjcard.2017.06.036. Epub 2017 Jun 29.

PMID:
28754566
8.

Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.

Fearon WF, Okada K, Kobashigawa JA, Kobayashi Y, Luikart H, Sana S, Daun T, Chmura SA, Sinha S, Cohen G, Honda Y, Pham M, Lewis DB, Bernstein D, Yeung AC, Valantine HA, Khush K.

J Am Coll Cardiol. 2017 Jun 13;69(23):2832-2841. doi: 10.1016/j.jacc.2017.03.598.

9.

The effect of negative remodeling on fractional flow reserve after cardiac transplantation.

Fearon WF, Felix R, Hirohata A, Sakurai R, Jose PO, Yamasaki M, Nakamura M, Fitzgerald PJ, Valantine HA, Yock PG, Yeung AC.

Int J Cardiol. 2017 Aug 15;241:283-287. doi: 10.1016/j.ijcard.2017.04.020. Epub 2017 Apr 8.

PMID:
28413112
10.

Science Has a Gender Problem.

Valantine HA.

Sci Am. 2016 Nov 15;315(6):12. doi: 10.1038/scientificamerican1216-12. No abstract available.

PMID:
28004668
11.

From the NIH: A Systems Approach to Increasing the Diversity of the Biomedical Research Workforce.

Valantine HA, Lund PK, Gammie AE.

CBE Life Sci Educ. Fall 2016;15(3). pii: fe4. doi: 10.1187/cbe.16-03-0138.

12.

Advancing the Progress of Mentoring for Diversity in AIDS Research: Warming the Mentoring Climate.

Valantine HA.

AIDS Behav. 2016 Sep;20 Suppl 2:219-21. doi: 10.1007/s10461-016-1490-y. No abstract available.

13.

Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.

Okada K, Fearon WF, Luikart H, Kitahara H, Otagiri K, Tanaka S, Kimura T, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Khush KK, Honda Y.

J Am Coll Cardiol. 2016 Jul 26;68(4):382-92. doi: 10.1016/j.jacc.2016.05.028.

14.

Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma.

Burnham P, Kim MS, Agbor-Enoh S, Luikart H, Valantine HA, Khush KK, De Vlaminck I.

Sci Rep. 2016 Jun 14;6:27859. doi: 10.1038/srep27859.

15.

Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation.

Okada K, Kitahara H, Yang HM, Tanaka S, Kobayashi Y, Kimura T, Luikart H, Yock PG, Yeung AC, Valantine HA, Fitzgerald PJ, Khush KK, Honda Y, Fearon WF.

JACC Heart Fail. 2015 Dec;3(12):942-52. doi: 10.1016/j.jchf.2015.07.013. Epub 2015 Nov 11.

16.

Monitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy study.

Vollmers C, De Vlaminck I, Valantine HA, Penland L, Luikart H, Strehl C, Cohen G, Khush KK, Quake SR.

PLoS Med. 2015 Oct 14;12(10):e1001890. doi: 10.1371/journal.pmed.1001890. eCollection 2015 Oct.

17.

National Institutes of Health addresses the science of diversity.

Valantine HA, Collins FS.

Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12240-2. doi: 10.1073/pnas.1515612112. Epub 2015 Sep 21.

18.

Gene expression profiling to study racial differences after heart transplantation.

Khush KK, Pham MX, Teuteberg JJ, Kfoury AG, Deng MC, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Hiller D, Yee J, Valantine HA.

J Heart Lung Transplant. 2015 Jul;34(7):970-7. doi: 10.1016/j.healun.2015.01.987. Epub 2015 Feb 7.

19.

Teaching corporate in college.

Valantine HA, Beckerle MC, Reed KL, Towner D, Zahniser NR.

Sci Transl Med. 2014 Aug 27;6(251):251fs33. doi: 10.1126/scitranslmed.3009450.

PMID:
25163476
20.

Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.

De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Bernstein D, Weisshaar D, Quake SR, Khush KK.

Sci Transl Med. 2014 Jun 18;6(241):241ra77. doi: 10.1126/scitranslmed.3007803.

21.

The gender gap in academic medicine: comparing results from a multifaceted intervention for stanford faculty to peer and national cohorts.

Valantine HA, Grewal D, Ku MC, Moseley J, Shih MC, Stevenson D, Pizzo PA.

Acad Med. 2014 Jun;89(6):904-11. doi: 10.1097/ACM.0000000000000245.

22.

Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients.

Deng MC, Elashoff B, Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Shahzad K, Hiller D, Yee J, Valantine HA; IMAGE Study Group.

Transplantation. 2014 Mar 27;97(6):708-14. doi: 10.1097/01.TP.0000443897.29951.cf.

23.

Temporal response of the human virome to immunosuppression and antiviral therapy.

De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, Okamoto J, Snyder TM, Cornfield DN, Nicolls MR, Weill D, Bernstein D, Valantine HA, Quake SR.

Cell. 2013 Nov 21;155(5):1178-87. doi: 10.1016/j.cell.2013.10.034.

24.

Transdisciplinary translational science and the case of preterm birth.

Stevenson DK, Shaw GM, Wise PH, Norton ME, Druzin ML, Valantine HA, McFarland DA; March of Dimes Prematurity Research Center at Stanford University School of Medicine.

J Perinatol. 2013 Apr;33(4):251-8. doi: 10.1038/jp.2012.133. Epub 2012 Oct 18. Review.

25.

Medical faculty development: a modern-day odyssey.

Beckerle MC, Reed KL, Scott RP, Shafer MA, Towner D, Valantine HA, Zahniser NR.

Sci Transl Med. 2011 Oct 12;3(104):104cm31. doi: 10.1126/scitranslmed.3002763.

PMID:
21998405
26.

Identification and classification of acute cardiac rejection by intragraft transcriptional profiling.

Holweg CT, Potena L, Luikart H, Yu T, Berry GJ, Cooke JP, Valantine HA, Mocarski ES.

Circulation. 2011 May 24;123(20):2236-43. doi: 10.1161/CIRCULATIONAHA.109.913921. Epub 2011 May 9.

27.

Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis.

Yamasaki M, Sakurai R, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.

Transplantation. 2011 Jun 27;91(12):1406-11. doi: 10.1097/TP.0b013e31821ab91b.

PMID:
21512436
28.

Universal noninvasive detection of solid organ transplant rejection.

Snyder TM, Khush KK, Valantine HA, Quake SR.

Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6229-34. doi: 10.1073/pnas.1013924108. Epub 2011 Mar 28.

29.

Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions.

Chen R, Sigdel TK, Li L, Kambham N, Dudley JT, Hsieh SC, Klassen RB, Chen A, Caohuu T, Morgan AA, Valantine HA, Khush KK, Sarwal MM, Butte AJ.

PLoS Comput Biol. 2010 Sep 23;6(9). pii: e1000940. doi: 10.1371/journal.pcbi.1000940.

30.

Gene-expression profiling for rejection surveillance after cardiac transplantation.

Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Elashoff B, Baron H, Yee J, Valantine HA; IMAGE Study Group.

N Engl J Med. 2010 May 20;362(20):1890-900. doi: 10.1056/NEJMoa0912965. Epub 2010 Apr 22.

31.

New developments in immunosuppressive therapy for heart transplantation.

Khush KK, Valantine HA.

Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21. doi: 10.1517/14728210902791605 . Review.

PMID:
19265486
32.

Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation.

Sinha SS, Pham MX, Vagelos RH, Perlroth MG, Hunt SA, Lee DP, Valantine HA, Yeung AC, Fearon WF.

Am Heart J. 2008 May;155(5):889.e1-6. doi: 10.1016/j.ahj.2008.02.004.

PMID:
18440337
33.

Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.

Potena L, Fearon WF, Sydow K, Holweg C, Luikart H, Chin C, Weisshaar D, Mocarski ES, Lewis DB, Valantine HA, Cooke JP.

Transplantation. 2008 Mar 27;85(6):827-33. doi: 10.1097/TP.0b013e318166a3a4.

PMID:
18360263
34.

Determinants of lumen loss between years 1 and 2 after cardiac transplantation.

Sakurai R, Yamasaki M, Nakamura M, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.

Transplantation. 2007 Nov 15;84(9):1097-102.

PMID:
17998863
35.

Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Potena L, Valantine HA.

Endocrinol Metab Clin North Am. 2007 Dec;36(4):965-81; ix. Review.

36.

Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness.

Kuppahally SS, Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, Fowler M, Vagelos R, Perlroth MG, Robbins RC, Hunt SA.

Am J Transplant. 2007 Oct;7(10):2388-95.

37.

Cytomegalovirus-associated allograft rejection in heart transplant patients.

Potena L, Valantine HA.

Curr Opin Infect Dis. 2007 Aug;20(4):425-31. Review.

PMID:
17609604
38.

Changes in coronary anatomy and physiology after heart transplantation.

Hirohata A, Nakamura M, Waseda K, Honda Y, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Yock PG, Fitzgerald PJ, Yeung AC, Fearon WF.

Am J Cardiol. 2007 Jun 1;99(11):1603-7. Epub 2007 Apr 19.

39.

Changes in coronary arterial dimensions early after cardiac transplantation.

Fearon WF, Potena L, Hirohata A, Sakurai R, Yamasaki M, Luikart H, Lee J, Vana ML, Cooke JP, Mocarski ES, Yeung AC, Valantine HA.

Transplantation. 2007 Mar 27;83(6):700-5.

PMID:
17414701
40.

Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis.

Potena L, Holweg CT, Vana ML, Bashyam L, Rajamani J, McCormick AL, Cooke JP, Valantine HA, Mocarski ES.

J Clin Microbiol. 2007 Jun;45(6):1804-10. Epub 2007 Apr 4. Erratum in: J Clin Microbiol. 2008 Dec;46(12):4121.

41.

Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.

Biadi O, Potena L, Fearon WF, Luikart HI, Yeung A, Ferrara R, Hunt SA, Mocarski ES, Valantine HA.

J Heart Lung Transplant. 2007 Apr;26(4):324-30.

PMID:
17403472
42.

[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome].

Potena L, Ferrara R, Mocarski ES, Lewis DB, Cooke JP, Grigioni F, Coccolo F, Magnani G, Fallani F, Magelli C, Valantine HA, Branzi A.

G Ital Cardiol (Rome). 2007 Feb;8(2):73-82. Review. Italian.

PMID:
17402351
43.
44.

T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.

Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, Valantine HA, Mocarski ES, Lewis DB.

Circulation. 2006 Oct 10;114(15):1608-15. Epub 2006 Oct 2.

PMID:
17015794
45.

Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.

Potena L, Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke JP, Mocarski ES, Valantine HA.

Transplantation. 2006 Aug 15;82(3):398-405.

PMID:
16906040
46.

Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study.

Fearon WF, Hirohata A, Nakamura M, Luikart H, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Fitzgerald PJ, Yock PG, Yeung AC.

J Heart Lung Transplant. 2006 Jul;25(7):765-71. Epub 2006 May 24.

PMID:
16818118
47.

Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation.

Ma IW, Valantine HA, Shibata A, Waskerwitz J, Dafoe DC, Alfrey EJ, Tan JC, Millan M, Busque S, Scandling JD.

Clin Transplant. 2006 Mar-Apr;20(2):139-46.

PMID:
16640517
48.

Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.

Kobashigawa JA, Tobis JM, Mentzer RM, Valantine HA, Bourge RC, Mehra MR, Smart FW, Miller LW, Tanaka K, Li H, Gjertson DW, Gordon RD.

Am J Transplant. 2006 May;6(5 Pt 1):993-7.

49.

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.

Kuppahally S, Al-Khaldi A, Weisshaar D, Valantine HA, Oyer P, Robbins RC, Hunt SA.

Am J Transplant. 2006 May;6(5 Pt 1):986-92.

50.

Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis.

Kuppahally SS, Hunt SA, Valantine HA, Berry GJ.

J Heart Lung Transplant. 2006 Jan;25(1):144-7. Epub 2005 Nov 10.

PMID:
16399547

Supplemental Content

Loading ...
Support Center